UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Cardiovascular magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities

Quarta, G; Gori, M; Iorio, A; D'Elia, E; Moon, JC; Iacovoni, A; Burocchi, S; ... Senni, M; + view all (2020) Cardiovascular magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities. European Journal of Heart Failure , 22 (7) pp. 1065-1075. 10.1002/ejhf.1961. Green open access

[thumbnail of Moon_Cardiovascular magnetic resonance in heart failure with preserved ejection fraction_AAM.pdf]
Preview
Text
Moon_Cardiovascular magnetic resonance in heart failure with preserved ejection fraction_AAM.pdf - Accepted Version

Download (5MB) | Preview

Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) is a chronic cardiac condition whose prevalence continues to rise, with high social and economic burden, but with no specific approved treatment. Patients diagnosed with HFpEF have a high prevalence of comorbidities and there is a likely high misdiagnosis rate. True HFpEF is likely to have multiple pathophysiological causes – with these causes themselves clinically ill‐defined through limitations of current measurement techniques. Myocyte, interstitium, microvascular, and metabolic abnormalities have been regarded as key components of the pathophysiology and potential therapeutic targets. Cardiac magnetic resonance (CMR) has the capability to look deeper with a number of tissue characterization techniques which are closer to the underlying specific abnormalities and which could be linked to personalized medicine for HFpEF. This review aims to discuss the potential role of CMR to better define HFpEF phenotypes and to infer measurable therapeutic targets.

Type: Article
Title: Cardiovascular magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ejhf.1961
Publisher version: https://doi.org/10.1002/ejhf.1961
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10106054
Downloads since deposit
1,444Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item